A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants

NCT05053165 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Non-Alcoholic Steatohepatitis

Interventions

DRUG: LB-P6
DRUG: LB-P8
DRUG: Placebo

Sponsor

LISCure Biosciences